Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Computer-Aided Molecular Design|September 16, 2005
Association of cytochrome P450 enzymes is a determining factor in their catalytic activityEszter Hazai, Zsolt Bikádi, Miklós Simonyi, et al.Expert Opinion on Drug Metabolism & Toxicology|September 30, 2010
Drug transport by breast cancer resistance proteinMaren Poguntke, Eszter Hazai, Martin F Fromm, et al.Bioorganic & Medicinal Chemistry|May 24, 2006
Molecular modeling of non-covalent binding of homochiral (3S,3'S)-astaxanthin to matrix metalloproteinase-13 (MMP-13)Zsolt Bikádi, Eszter Hazai, Ferenc Zsila, et al.Bioorganic & Medicinal Chemistry|July 14, 2006
Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenaseEszter Hazai, Zsolt Bikádi, Ferenc Zsila, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 4, 2005
Role of CYP2E1 in deramciclane metabolismKatalin Monostory, Krisztina Köhalmy, Eszter Hazai, et al.Chemmedchem|May 20, 2014
A detailed study of antibacterial 3-acyltetramic acids and 3-acylpiperidine-2,4-dionesYong-Chul Jeong, Zsolt Bikadi, Eszter Hazai, et al.Bioorganic & Medicinal Chemistry|November 18, 2005
Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variantsEszter Hazai, Júlia Visy, Ilona Fitos, et al.Chemistry & Biodiversity|December 29, 2006
Aggregation of cyclodextrins as an important factor to determine their complexation behaviorZsolt Bikádi, Róbert Kurdi, Sándor Balogh, et al.Current Drug Discovery Technologies|November 30, 2007
Cyclodextrin complexes: chiral recognition and complexation behaviourZsolt Bikádi, Róbert Iványi, Lajos Szente, et al.Biochimica Et Biophysica Acta|May 6, 2008
Organogold complexes probe a large beta-barrel cavity for human serum alpha1-acid glycoproteinFerenc Zsila, Zsolt Bikádi, Eszter Hazai, et al.Pageof 4